Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer

Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer

US Patent 10611766 · Granted Apr 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulators of rho-associated protein kinase2025
Compounds useful as kinase inhibitors2025
Modulators of Rho-associated protein kinase2024
Compounds useful as kinase inhibitors2023
Modulators of Rho-associated protein kinase2022
Compounds useful as kinase inhibitors2022
Compounds useful as kinase inhibitors2021
Compounds useful as kinase inhibitors2020
Pyrazolopyrimidine derivatives useful as inhibitors of Bruton's tyrosine kinase2020
Compounds useful as kinase inhibitors2019
Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer2019
Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer2019